Astrana Health (ASTH) to Release Quarterly Earnings on Tuesday

Astrana Health (NASDAQ:ASTHGet Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.32 per share for the quarter. Astrana Health has set its FY24 guidance at $1.28-$1.52 EPS and its FY 2024 guidance at 1.280-1.520 EPS.Parties that wish to register for the company’s conference call can do so using this link.

Astrana Health (NASDAQ:ASTHGet Free Report) last issued its earnings results on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.09. The company had revenue of $353.00 million during the quarter, compared to analysts’ expectations of $341.17 million. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The firm’s quarterly revenue was up 20.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.02 EPS. On average, analysts expect Astrana Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Astrana Health Trading Up 1.5 %

NASDAQ:ASTH traded up $0.58 during trading hours on Monday, hitting $38.04. The company had a trading volume of 1,900 shares, compared to its average volume of 153,103. The company has a current ratio of 2.11, a quick ratio of 2.11 and a debt-to-equity ratio of 0.42. The business’s 50-day moving average price is $40.56. The firm has a market capitalization of $2.13 billion, a P/E ratio of 28.38, a P/E/G ratio of 1.20 and a beta of 1.12. Astrana Health has a 1 year low of $28.86 and a 1 year high of $45.71.

Analysts Set New Price Targets

Several analysts have issued reports on ASTH shares. Truist Financial upped their target price on Astrana Health from $41.00 to $44.00 and gave the company a “hold” rating in a report on Friday, March 1st. Jefferies Financial Group started coverage on Astrana Health in a report on Monday, February 26th. They issued a “buy” rating and a $50.00 target price for the company.

Check Out Our Latest Stock Analysis on ASTH

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Articles

Earnings History for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.